India Today on MSN
Shot in the arm for Indian drugmakers as US FDA moves to ease biosimilar approvals
A proposed move by the US Food and Drug Administration (FDA) to accelerate development and ease approval of biosimilars could ...
Zydus Lifesciences and its wholly owned subsidiary, Zydus Lifesciences Global FZE, have entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for ozanimod ...
The brokerage has maintained a ‘Positive’ sector view, forecasting EBITDA margins to remain “broadly stable” as companies ...
Zydus Lifesciences Limited ( ($IN:ZYDUSLIFE) ) has provided an announcement. Zydus Lifesciences Limited has completed the acquisition of Amplitude ...
Analysts believe Indian pharma companies, primarily focused on generics, will largely avoid impact due to the tariffs being ...
NDTV Profit on MSN
Pharma Q2FY26 Preview: Sector Faces a Transition Quarter as gRevlimid Declines and GST Impact Weigh on Growth
Brokerages expect soft growth in Q2FY26 for pharma companies as waning gRevlimid sales, a weak acute season in India, and GST ...
Dr. Reddy’s may slip on Canada notice; Concor, Ashoka Buildcon, Solex Energy, Samvardhana Motherson, Sharda Motor and Zydus ...
Zydus Lifesciences Limited and Zydus Pharmaceuticals Inc. were hit with a patent infringement lawsuit on Oct. 15 in Delaware District Court. The lawsuit, brought by McCarter & English and Arnold & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback